Latest News

Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

  • April 29, 2019 10:02 AM | Anonymous

    April 29, 2019, MedPage Today OB/GYN Update  

    Pregnant people should continue to be screened for asymptomatic bacteriuria via urine culture, the U.S. Preventive Services Task Force (USPSTF) said.

    Screening for and treating asymptomatic bacteriuria in pregnancy has moderate net benefit in reducing perinatal complications (B recommendation), which is a change from the 2008 A recommendation.

    Read more. 
  • April 29, 2019 9:52 AM | Anonymous

    April 29, 2019, HealthDay News via WebMD 

    Antibiotics can be lifesaving, but using them over a long period might raise the odds of heart disease and stroke in older women, a new study suggests. Researchers tracked the health of nearly 36,500 U.S. women over an average follow-up of nearly eight years. During that time, more than a thousand developed heart disease. The study found that women aged 60 and older who used antibiotics for two months or longer were 32% percent more likely to develop heart disease than those who did not use antibiotics.  

    Read more.

  • April 29, 2019 9:48 AM | Anonymous

    April 29, 2019, Medical News Bulletin 

    Small cell carcinoma accounts for about 0.1% of ovarian cancer cases with reported long-term survival rates of 33% when the disease is diagnosed at an early stage. Of these, about two-thirds of women with small cell carcinoma of the ovaries have hypercalcemia (SCCOHT — small cell carcinoma of the ovary, hypercalcemic type). Researchers discovered that inhibition of certain enzymes called cyclin-dependent kinases 4 and 6 (CDK4/6) blocked the growth of SCCOHT cancer cells.  

    Read more.

  • April 26, 2019 9:09 AM | Anonymous

    April 26, 2019, Medscape 

    Six factors are associated with the eventual development of invasive breast cancer after an initial diagnosis of ductal carcinoma in situ (DCIS), an often benign condition, according to a new Dutch meta-analysis.

    Read more.

  • April 25, 2019 9:33 AM | Anonymous

    April 24, 2019, HemOnc Today  

    Screening with 3-D digital breast tomosynthesis appeared associated with increases in both specificity and proportion of breast cancers detected with better prognosis than two-dimensional digital mammography, according to results of a retrospective observational study published in JAMA Oncology. The findings were especially true for a subgroup of women age 40 to 49.  

    Read more.

  • April 24, 2019 8:38 AM | Anonymous

    April 24, 2019, HealthDay News 

    A type of cervical cancer that's less sensitive to Pap testing is increasing among white women in the United States, new research shows. An overall decline in cervical cancer rates in recent decades has been driven by decreases in squamous cell carcinomas. Most of the rest of cervical cancer cases are adenocarcinomas, which are less likely to be detected by Pap testing and are mainly caused by the human papillomavirus (HPV).

    Read more.

  • April 24, 2019 8:32 AM | Anonymous

    April 24, 2019, Medgadget 

    Preeclampsia is one of the most common serious maladies that pregnant women encounter. It is a poorly understood condition with symptoms such as high blood pressure, proteinuria, and headaches, potentially even leading to seizures. The treatment options for preeclampsia are still very limited, mostly confined to hypertension medications, bed rest, and birthing the baby, which is essentially a cure for the disease. A new option has just been given Breakthrough Device Designation by the U.S. Food and Drug Administration. 

    Read more.

  • April 22, 2019 9:55 AM | Anonymous

    April 22, 2019, Medical News Today 

    Leucine, an amino acid that the body needs for making protein, appears to have a surprising role in the development of resistance to tamoxifen in breast cancer that tests positive for the estrogen receptor. Scientists from Harvard Medical School recently made this "unexpected" discovery about estrogen receptor-positive breast cancer in a study conducted with colleagues from other research centers. 

    Read more.

  • April 22, 2019 9:54 AM | Anonymous

    April 22, 2019, Contemporary Clinic  

    The first and only FDA-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral daily capsule for the treatment of moderate-to-severe vasomotor symptoms, BijuvaTM, from Therapeutics MD is now commercially available in the U.S., according to a press release from the company. Bijuva offers a proven balance of bio-identical estradiol combined with bio-identical progesterone to reduce risk to the endometrium in women with a uterus, according to the release. 

    Read more.

  • April 19, 2019 11:46 AM | Anonymous

    April 19, 2019, MedPage Today  

    A type of cervical cancer often missed by Pap testing was seen at increasing rates over the past 15 years in the U.S., whereas rates of the most common histology decreased, a review of a cancer database showed. 

    Read more.

Powered by Wild Apricot Membership Software